These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 19211583

  • 1. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [Abstract] [Full Text] [Related]

  • 2. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K, Hoch S, Dima C, Varga J, Teodorescu M.
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [Abstract] [Full Text] [Related]

  • 3. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS, Fisicaro N, McNeilage LJ, Coppel RL, Harrison LC.
    J Immunol; 1993 Dec 15; 151(12):6872-81. PubMed ID: 7505017
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May 15; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 5. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
    Kuwana M, Kaburaki J, Medsger TA, Wright TM.
    Arthritis Rheum; 1999 Jun 15; 42(6):1179-88. PubMed ID: 10366110
    [Abstract] [Full Text] [Related]

  • 6. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
    Rizou C, Ioannidis JP, Panou-Pomonis E, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM, Vlachoyiannopoulos PG.
    Am J Respir Cell Mol Biol; 2000 Mar 15; 22(3):344-51. PubMed ID: 10696071
    [Abstract] [Full Text] [Related]

  • 7. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.
    Arthritis Rheum; 2004 Oct 15; 50(10):3265-74. PubMed ID: 15476238
    [Abstract] [Full Text] [Related]

  • 8. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug 15; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 9. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec 15; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 10. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T, Simon D, Czirják L, Németh P.
    Autoimmun Rev; 2009 Jul 15; 8(8):692-6. PubMed ID: 19393194
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M.
    J Rheumatol; 2002 Jan 15; 29(1):90-3. PubMed ID: 11824977
    [Abstract] [Full Text] [Related]

  • 12. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arch Dermatol Res; 2005 Oct 15; 297(4):180-3. PubMed ID: 16180014
    [Abstract] [Full Text] [Related]

  • 13. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
    Hu PQ, Oppenheim JJ, Medsger TA, Wright TM.
    J Autoimmun; 2006 Jun 15; 26(4):258-67. PubMed ID: 16735104
    [Abstract] [Full Text] [Related]

  • 14. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
    Henry PA, Atamas SP, Yurovsky VV, Luzina I, Wigley FM, White B.
    Arthritis Rheum; 2000 Dec 15; 43(12):2733-42. PubMed ID: 11145031
    [Abstract] [Full Text] [Related]

  • 15. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y.
    J Dermatol; 2010 Jan 15; 37(1):42-53. PubMed ID: 20175839
    [Abstract] [Full Text] [Related]

  • 16. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
    Gergely P, Pullmann R, Stancato C, Otvos L, Koncz A, Blazsek A, Poor G, Brown KE, Phillips PE, Perl A.
    Clin Immunol; 2005 Aug 15; 116(2):124-34. PubMed ID: 15894513
    [Abstract] [Full Text] [Related]

  • 17. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M, Fritzler MJ, Blüthner M.
    Arthritis Res Ther; 2005 Aug 15; 7(1):R19-29. PubMed ID: 15642139
    [Abstract] [Full Text] [Related]

  • 18. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb 15; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

  • 19. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G, Grieco A, Nacci G, Paolini C, Tonnini C, Pozniak KN, Cuccioloni M, Mozzicafreddo M, Svegliati S, Angeletti M, Kazlauskas A, Avvedimento EV, Funaro A, Gabrielli A.
    Arthritis Rheumatol; 2015 Jul 15; 67(7):1891-903. PubMed ID: 25808833
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
    Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P.
    J Rheumatol; 2000 Jan 15; 27(1):109-15. PubMed ID: 10648026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.